Trevi Therapeutics, Inc. (TRVI) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $193.44M | +74.4% |
| 2024 | $110.90M | +24.0% |
| 2023 | $89.40M | -27.3% |
| 2022 | $123.02M | +219.7% |
| 2021 | $38.48M | -18.4% |
| 2020 | $47.13M | -21.4% |
| 2019 | $60.00M | +470.0% |
| 2018 | $10.53M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $193.44M | +74.4% |
| 2024 | $110.90M | +24.0% |
| 2023 | $89.40M | -27.3% |
| 2022 | $123.02M | +219.7% |
| 2021 | $38.48M | -18.4% |
| 2020 | $47.13M | -21.4% |
| 2019 | $60.00M | +470.0% |
| 2018 | $10.53M | — |